Accéder au contenu
MilliporeSigma
  • Synthesis, NMR characterization and divergent biological actions of 2'-hydroxy-ceramide/dihydroceramide stereoisomers in MCF7 cells.

Synthesis, NMR characterization and divergent biological actions of 2'-hydroxy-ceramide/dihydroceramide stereoisomers in MCF7 cells.

Bioorganic & medicinal chemistry (2010-09-21)
Zdzislaw M Szulc, Aiping Bai, Jacek Bielawski, Nalini Mayroo, Doreen E Miller, Hanna Gracz, Yusuf A Hannun, Alicja Bielawska
RÉSUMÉ

A straightforward method for the simultaneous preparation of (2S,3R,2'R)- and (2S,3R,2'S)-2'-hydroxy-ceramides (2'-OHCer) from (2S,3R)-sphingosine acetonide precursors and racemic mixtures of 2-hydroxy fatty acids (2-OHFAs) is described. The obtained 2'-OH-C4-, -C6-, -C12-, -C16-Cer and 2'-OH-C6-dhCer pairs of diastereoisomers were characterized thoroughly by TLC, MS, NMR, and optical rotation. Dynamic and multidimensional NMR studies provided evidence that polar interfaces of 2'-OHCers are extended and more rigid than observed for the corresponding non-hydroxylated analogs. Stereospecific profile on growth suppression of MCF7 cells was observed for (2'R)- and (2'S)-2'-OH-C6-Cers and their dihydro analogs. The (2'R)-isomers were more active than the (2'S)-isomers (IC(50) ∼3 μM/8 μM and IC(50) ∼8 μM/12 μM, respectively), surpassing activity of the ordinary C6-Cer (IC(50) ∼12 μM) and C6-dhCer (IC(50) ∼38 μM). Neither isomer of 2'-OH-C6-Cers and 2'-OH-C6-dhCers was metabolized to their cellular long chain 2'-OH-homologs. Surprisingly, the most active (2'R)-isomers did not influence the levels of the cellular Cers nor dhCers. Contrary to this, the (2'S)-isomers generated cellular Cers and dhCers efficiently. In comparison, the ordinary C6-Cer and C6-dhCer also significantly increased the levels of their cellular long chain homologs. These peculiar anabolic responses and SAR data suggest that (2'R)-2'-OHCers/dhCers may interact with some distinct cellular regulatory targets in a specific and more effective manner than their non-hydroxylated analogs. Thus, stereoisomers of 2'-OHCers can be potentially utilized as novel molecular tools to study lipid-protein interactions, cell signaling phenomena and to understand the role of hydroxylated sphingolipids in cancer biology, pathogenesis and therapy.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
N-Hexanoyl-D-sphingosine, ≥98% (TLC), synthetic
Avanti
18:0(2S-OH) Ceramide, Avanti Research - A Croda Brand 860830P, powder
Avanti
24:0(2R-OH) Ceramide, Avanti Research - A Croda Brand 860823P, powder
Avanti
12:0(2S-OH) Ceramide, Avanti Research - A Croda Brand 860812P, powder
Avanti
18:0(2R-OH) Ceramide, Avanti Research - A Croda Brand 860829P, powder
Avanti
16:0(2R-OH) Ceramide, Avanti Research - A Croda Brand 860815P, powder
Avanti
24:0(2S-OH) Ceramide, Avanti Research - A Croda Brand 860824P, powder
Avanti
12:0(2R-OH) Ceramide, Avanti Research - A Croda Brand 860811P, powder
Avanti
18:1(2R-OH) Ceramide, Avanti Research - A Croda Brand 860827P, powder
Avanti
17:0(2R-OH) Ceramide, Avanti Research - A Croda Brand 860817P, powder
Avanti
16:0(2S-OH) Ceramide, Avanti Research - A Croda Brand 860816P, powder
Avanti
22:0(2R-OH) Ceramide, Avanti Research - A Croda Brand 860821P, powder
Avanti
24:1(2R-OH) Ceramide, Avanti Research - A Croda Brand 860825P, powder
Avanti
22:0(2S-OH) Ceramide, Avanti Research - A Croda Brand 860822P, powder
Avanti
20:0(2R-OH) Ceramide, Avanti Research - A Croda Brand 860819P, powder
Avanti
17:0(2S-OH) Ceramide, Avanti Research - A Croda Brand 860818P, powder
Avanti
20:0(2S-OH) Ceramide, Avanti Research - A Croda Brand 860820P, powder
Avanti
18:1(2S-OH) Ceramide, Avanti Research - A Croda Brand 860828P, powder